InsiderTrades

Form 4 for HCA HCA Healthcare

Accepted 2022-11-01 00:00:00 ET · period of report 2022-10-28 · accession 0001209191-22-055127 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-11-01 2022-10-28 HCA Hall Charles J Group Pres M - OptEx $127.93 +31.1K 210.8K +17% +$3.98M
D 2022-11-01 2022-10-28 HCA Hall Charles J Group Pres S - Sale+OE $223.50 -9,838 199.9K -5% -$2.20M
D 2022-11-01 2022-10-28 HCA Hall Charles J Group Pres F - Tax $223.66 -23.1K 209.7K -10% -$5.16M
DM 2022-11-01 2022-10-28 HCA Hall Charles J Group Pres M - OptEx $0.00 -31.1K 7,333 -81% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-10-28 M A 21,997 $139.06 232,785 D — —
2 Common Common Stock 2022-10-28 M A 9,150 $101.16 210,788 D — —
3 Common Common Stock 2022-10-28 S D 9,838 $223.50 199,883 D — —
4 Common Common Stock 2022-10-28 F D 23,064 $223.66 209,721 D — —
5 Derivative Stock Appreciation Right 2022-10-28 M D 9,150 $0.00 0 D $101.16 · — to 2028-01-31 9,150 Common Stock (F1) The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.
6 Derivative Stock Appreciation Right 2022-10-28 M D 21,997 $0.00 7,333 D $139.06 · — to 2029-01-30 21,997 Common Stock (F2) The stock appreciation rights vest in four equal annual installments beginning on January 30, 2020.